MUMBAI: Some 66 deaths of children in Gambia after consumption of four cough syrups made by the Haryana-based Maiden Pharmaceuticals, the subsequent recall of the drugs by the West African country and a WHO alert have put the spotlight on quality monitoring and due diligence by companies, and the need for stricter policing by regulators.
India has also had its fair share of tragedies due to “poisonous”, sub-standard or spurious formulations. Hence, quality control needs to be stringent, with criminal and financial liability on the perpetrators, industry experts told TOI.
